Purpose: This study presents a comparison of the international experience with ipsilateral and bilateral ureteroscopy for multiple, bilateral ureteral and renal stones vs single stone treatment. Patient and treatment characteristics and outcomes were compared. Materials and Methods: The CROES (Clinical Research Office of the Endourological Society) Ureteroscopy Global Study includes 114 centers in 32 countries. Patients undergoing bilateral ureteroscopy, ipsilateral ureteroscopy for multiple stones and ureteroscopy for a single stone were examined from January 2010 to October 2012. Intraoperative characteristics and postoperative outcomes were identified for each patient. Inverse probability weighted regression adjustment analyses were done to compare outcomes independent of differences among centers and patient characteristics. Results: The CROES Ureteroscopy Global Study consists of 11,885 patients. A total of 2,153 patients (18.7%) were treated for multiple stones, of whom 1,880 (87.3%) and 273 (12.7%) underwent ipsilateral and bilateral ureteroscopy, respectively. Inverse probability weighted regression adjustment models for bilateral vs ipsilateral ureteroscopy and multiple vs single stone treatments showed that patients with bilateral ureteroscopy and multiple stone treatments had lower stone-free rates, higher re-treatment rates and longer operative times compared to patients who underwent ipsilateral ureteroscopy and single stone treatment. There was no difference in complication rates among bilateral, ipsilateral and single stone ureteroscopy. Conclusions: This study presents a large series of patients who underwent bilateral and ipsilateral ureteroscopy. Our findings suggest a decrease in stonefree rates, increased re-treatment rates, increased operative times and longer hospital stay in patients treated for multiple stones. The treatment of multiple Accepted for publication January 29, 2017. No direct or indirect commercial incentive associated with publishing this article. The corresponding author certifies that, when applicable, a statement(s) has been included in the manuscript documenting institutional review board, ethics committee or ethical review board study approval; principles of Helsinki Declaration were followed in lieu of formal ethics committee approval; institutional animal care and use committee approval; all human subjects provided written informed consent with guarantees of confidentiality; IRB approved protocol number; animal approved project number.
stones and bilateral ureteroscopy are safe compared to single stone treatment and ipsilateral ureteroscopy, respectively.
Key Words: ureter, kidney, calculi, ureteroscopy, treatment outcome DURING the last 2 decades advances in the flexibility, size and optics of digital and fiberoptic ureteroscopes along with the development of novel grasping devices, ureteral access sheaths and laser fibers have enabled the urologist to efficiently and safely access and treat stones in virtually all parts of the urinary tract.
1e3 As a result EAU (European Association of Urology) and AUA (American Urological Association)/ES (Endourological Society) guidelines now recommend ureteroscopy as the first line therapeutic option for ureteral and renal calculi. 2, 3 Approximately 25% of patients present with multiple stones. Since 30% of asymptomatic stones eventually become symptomatic, 4 many urologists routinely treat patients with multiple ipsilateral stones while under a single anesthetic. 5e10 As ureteroscopy is generally well tolerated and associated with a low complication rate, many advocate a single session to treat bilateral stones as well. Recent studies examining I-URS suggest that this approach is associated with longer procedure times, higher ureteral stent placement rates and longer stent dwell times. 5, 6, 16 I-URS does not increase hospital length of stay and compared to URS for a single stone similar success rates are seen with comparable complication rates. 5, 16 By treating asymptomatic renal stones during the treatment of symptomatic ureteral stones the need for auxiliary therapies may decrease along with potentially preventing future episodes of renal colic.
14 Some studies of I-URS suggest that there are safety and efficacy only with smaller stones. 7, 9, 12 B-URS is more controversial than I-URS due to the potentially increased risk of bilateral complications.
14 Recent studies of B-URS show that it is safe and efficient for smaller stones, 11e16 although it is associated with longer operative time.
14 In addition, patients undergoing B-URS are more likely to have a ureteral stent placed postoperatively and have the stent left in situ for a longer time. 13, 15 Complication rates may also be higher with B-URS compared with unilateral procedures. 12, 15 As with any endourological treatment, the success rates of I-URS and B-URS are affected by stone, clinical, anatomical and technical factors. Although percutaneous nephrolithotomy remains the gold standard for treating large volume upper tract stones, I-URS and B-URS are reasonable treatment options for patients with multiple and bilateral stones, and a stone burden less than 20 mm.
We present an international experience with I-URS and B-URS for urolithiasis using data collected from the CROES Ureteroscopy Global Study. We compared I-URS and B-URS treatment characteristics and outcomes as well as the outcomes of treating multiple stones with I-URS and B-URS, and single stones.
METHODS
The CROES URS Global Study includes 114 centers in 32 countries. At all centers the CROES website (www. croesoffice.org) was used to enter data in an online available data management system between January 2010 and October 2012. The data were encrypted and stored in a central database at the CROES office. At all participating centers patients were treated according to local protocols for urolithiasis URS therapy. Institutional research board or institutional ethics committee approval was obtained at all participating centers prior to the study. Details of the content of data collection were described previously. 17 
Study Population
The CROES URS Global Study includes data on 11,885 patients, of whom 11,500 (96.8%) had information on the number of stones and 2,153 (18.7%) were identified as undergoing B-URS or I-URS. Various patient characteristics were collected, including age, gender, ASA score, BMI and urological history regarding congenital abnormalities, previous stone treatment and cardiovascular disease. Data on stone side and location were used to categorize patients as having multiple ipsilateral or bilateral stones ( fig. 1 ). Multiple ipsilateral stones were defined as more than 1 stone in the ipsilateral collecting system and bilateral stones were defined as stones on both sides of the urinary tract (renal and/or ureteral).
Intraoperative Characteristics
Operative data, including operative time (time from endoscope insertion to bladder catheter insertion), access sheath use (yes/no), type of URS (flexible/semirigid), postoperative stent placement (yes/no) and intraoperative complications were recorded. Intraoperative complications (yes/no) were captured by the treating urologist in predefined categories. 18, 19 Complication severity was not captured.
Postoperative Outcomes
Postoperative assessment of SFRs varied and was left to the discretion of the urologist at each center. SFR was defined as the absence of stone or as fragments larger than 1 mm based on any imaging modality. Re-treatment rates, which included readmission and hospital stay longer than 1 day, were recorded. Postoperative complications were categorized according to the ClavienDindo grading system. 20, 21 A composite outcome of any intraoperative or postoperative complications (yes/no) was created.
Statistical Analyses
Descriptive information is presented as the mean AE SD for normally distributed variables, and the median and IQR for skewed continuous variables. Categorical variables are presented as frequencies and percentages. Percentages exclude missing values from denominators.
Univariate regression analyses were performed to test the univariate prediction of outcomes by single vs multiple stones and ipsilateral vs bilateral stones. For dichotomous outcomes logistic regression analysis was done. For the continuous variable of operative time linear regression analysis was performed using the natural logarithm of operative time since the variable did not meet the assumption of normal distribution.
As patients with multiple stones are likely to differ from those with a single stone and patients with bilateral stones are likely to differ from those with ipsilateral stones, IPWRA analyses were done. IPWRA is regression analysis in which inverse probability weights of baseline characteristics are used in a regression model describing the relationship of interest. Generally in an observational study the weighting adjustment removes sampling bias. 22 IPWRA analyses are performed in 3 steps. In step 1 the preoperative best fit prediction is calculated of having multiple stones over single stones or having bilateral over ipsilateral stones by age, gender, ASA score, BMI and medical history regarding congenital abnormalities, previous stone treatment, cardiovascular disease and preoperative stent placement. In IPWRA analysis step 2 the best prediction models of actual treatment outcomes (SFR, re-treatment, long hospital stay, complications and operative time) are calculated using intraoperative characteristics and possible confounders, including preoperative stent placement, URS type, postoperative stent placement, stone impaction, access sheath use, case volume and operative time. IPWRA analysis step 3 consists of combining the preoperative and intraoperative best prediction models with analyses of the adjusted relationship between B-URS vs I-URS and multiple vs single stone treatment with outcomes.
All analyses were performed with STATAÒ, version 13.
RESULTS
The CROES URS Global Figure 2 shows stone locations schematically. Table 1 lists clinical characteristics of patients treated with I-URS and B-URS. B-URS was more likely to be performed at high volume centers, in patients with fewer previous treatments, in those with lower rates of cardiovascular disease, in males and for longer operative times than I-URS. Postoperative hospital admission was not prolonged in B-URS cases and SFR was similar. The B-URS group was likely a select and healthier population with fewer comorbidities and previous treatments. Overall patients treated for multiple stones were more likely to have a preoperative ureteral stent and more likely to have a postoperative ureteral stent (both p <0.05) than patients treated for a single stone. Table 2 shows univariate analyses of B-URS vs I-URS and multiple vs single stone treatments. The univariate models of B-URS vs I-URS showed that patients with B-URS had lower SFRs, higher retreatment rates, longer operative times and longer postoperative hospital stays than patients who underwent I-URS. The univariate models of multiple vs single stone treatment showed that patients with multiple stone treatment had lower SFRs, higher re-treatment and complication rates, longer operative times and longer postoperative hospital stays.
Preoperative models to predict B-URS vs I-URS and single vs multiple stone treatments were calculated using a backward selection procedure. For single vs multiple stone treatment significant predictors were ASA score, case volume, operative time and previous stone treatment. For B-URS vs I-URS significant predictor variables were the presence of congenital abnormalities, stone location, case volume and previous treatment. The intraoperative Table 3 shows the final multivariate prediction models of IPWRA analyses comparing B-URS with I-URS and multiple with single stone treatment. The IPWRA models for B-URS use vs I-URS revealed that operative time was significantly longer in the B-URS group. When comparing B-URS to I-URS, B-URS was associated with a 5% lower SFR, a 6% higher re-treatment rate, 4% longer hospital stay and 3% more complications. However, those findings were not significant. These relationships were independent of baseline differences in ASA score, local case volume, operative time, previous stone treatment and intraoperative stone impaction, URS type, access sheath use and postoperative stent placement for single vs multiple stone treatment.
When B-URS vs I-URS variables were examined, there was no difference in the presence of congenital abnormalities, stone location, local case volume, previous treatment and intraoperative stone impaction, URS type, access sheath use and postoperative stent placement between B-URS and I-URS. The significant difference between B-URS and I-URS represents the average treatment effect or the effect attributable to undergoing B-URS. The final IPWRA models for multiple stones compared to single stones demonstrated that procedures for multiple stone treatments were significantly longer. These models also revealed 7% lower SFRs, 5% higher re-treatment rates and 3% longer hospital stays. No difference in complication rates was seen when ureteroscopy for multiple stones was compared to treatment for a single stone.
DISCUSSION
To our knowledge this study represents the largest series of patients undergoing URS for multiple bilateral and ipsilateral stones. Previous studies examining ipsilateral 5e11, 16 and bilateral single session 12e15 treatments were smaller, included select patients and were generally from a single center or surgeon (table 4) . 23, 24 Only 2 studies have examined the use of I-URS and B-URS. 11, 25 Current results indicate lower SFRs, higher retreatment rates, longer operative times and longer postoperative hospital stays in patients treated for multiple stones compared to patients treated for a single stone. Moreover, patients who undergo B-URS have lower SFRs, higher re-treatment rates, longer operative times and longer postoperative hospital stay compared to patients who undergo I-URS. There was no difference in B-URS, I-URS and single stone ureteroscopy complication rates. Number of patients on whom data were available and percents exclude missing values from denominators. As a limitation, it is possible that urologists contributing to the CROES database may have listed all stones in the database but only targeted and treated ureteral stones. There may have been no intent to treat renal calculi but then treatment may have failed due to remaining renal stones. Also, stone-free status was defined as the absence of fragments greater than 1 mm based on any imaging modality. However, the ability to identify 1 mm stone fragments largely depends on the type of imaging.
Stone-Free Rates

Re-Treatment and Readmission
Multiple vs single stone treatment and B-URS vs I-URS more often require re-treatment. This finding suggests that patients with multiple stones are a different type of stone former, which could possibly be explained by other lithogenic factors such as environment or genetics. 26 A limitation of the CROES URS database is that it is difficult to distinguish between re-treatment and readmission. A patient may be readmitted and undergo re-treatment or vice versa. To our knowledge it remains to be definitively determined whether treatment of bilateral stones and multiple ipsilateral stones during a single session compared to staged procedures in fact increases the long-term SFR and the symptom-free period.
Operative Time
The finding that procedure time is longer for multiple vs single and B-URS vs I-URS stone treatments is not unexpected. A larger stone burden will require more time to treat. Further insight could be attained by examining the patient cumulative lifetime stone operative time. While treating bilateral stones in 1 setting can increase operative time, the total number of access sheath insertions and ureteral stent placements can decrease potential complications and morbidity as well as potentially shorten patient cumulative lifetime operating room time. Undergoing 2 shorter separate general anesthetics might carry a fractionally higher anesthetic risk in patients. As a disadvantage of multiple A major advantage of the CROES URS Global Study is the ability to give a global perspective of URS for urolithiasis. The inclusion of multiple international centers also has a disadvantage. In some countries, predominantly the United States and Canada, most URS cases are performed in an outpatient setting. Patients undergoing URS in other countries such as The Netherlands are typically admitted for 24 hours. We currently defined a longer stay as 2 or more nights. Future studies should aim to collect more deviations from usual local practice than length of stay.
Complications
Current retrospective data suggest that although there is a perceived increased risk of damage to the urinary tract with B-URS, it is in fact not associated with a higher complication rate compared to that of I-URS. This matches findings in prior published studies. 5, 16 Statistical Methods The methods currently used are proposed to cover the heterogeneity between 2 populations that are compared. By using all patients compared to a subset of patients when performing matched case analyses, the current method has more power for estimations and population-wide conclusions since none of the cases is dropped. One could wonder what mainstream multivariate logistic and linear regression would have given as a result. We performed analyses with this approach as well (data not shown), in which we corrected for the same possible confounders. Although the numbers were slightly different, the results led to the same conclusions.
CONCLUSIONS
Treatment of multiple stones and B-URS are safe compared to single stone treatment and I-URS, respectively. However, the efficacy of multiple stone treatment remains debatable. Our findings suggest a decrease in SFRs, increased retreatment rates, increased operative times and a longer hospital stay in patients treated for multiple stones.
